Trials / Not Yet Recruiting
Not Yet RecruitingNCT07434895
Repeated CBD Administration and Cannabis Outcomes
The Effects of Repeated CBD Administration on Cannabis Abuse Liability and Analgesia: A Human Laboratory Study
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 23 (estimated)
- Sponsor
- Hannah Harris · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This outpatient study examines how cannabidiol (CBD) affects the behavioral and pain-relieving effects of cannabis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cannabidiol, Medium Dose | Active Cannabidiol: Active cannabidiol (medium dose) will be administered orally for 14 days. |
| DRUG | Cannabidiol, Higher Dose | Description: Active Cannabidiol: Active cannabidiol (higher dose) will be administered orally for 14 days. |
| DRUG | Active Inhaled Cannabis | Active Marijuana: Active Marijuana (active inhaled cannabis) will be administered through a vaporizer once per study session day (Day 1, 7, 14) per block (3 blocks total). |
| DRUG | Placebo Cannabidiol | Inactive/Placebo Cannabidiol: Inactive/placebo cannabidiol will be administered orally for 14 days. |
| DRUG | Placebo Inhaled Cannabis | Inactive/Placebo Marijuana: Experimental, non-therapeutic administration of an inactive/placebo marijuana dose will be administered through a vaporizer at each study session day (Days 1, 7, 14) per block (3 blocks total). |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2029-12-01
- Completion
- 2029-12-01
- First posted
- 2026-02-27
- Last updated
- 2026-02-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07434895. Inclusion in this directory is not an endorsement.